Supreme Court extends abortion pill access to Friday
The Supreme Court will make a decision on whether restrictions on mifepristone (Mifeprex; Danco Laboratories) should pass by Friday night.
Supreme Court extends abortion pill access to Friday | Image Credit: © tinnaporn - © tinnaporn - stock.adobe.com
Women’s access to an abortion pill has been extended to Friday by the US Supreme Court as justices debate if restrictions on mifepristone(Mifeprex; Danco Laboratories) should pass.
Justice Samuel Alito signed an order stating the court will come to a decision by Friday night, though a reason for delaying the decision was not provided.
Mifepristone, the most common method of abortion in the United States has been facing potential rollback on FDA approval from abortion opponents in Texas. The FDA approval was initially granted in 2000, with loosened conditions given in recent years such as availability by mail in certain states.
The Biden Administration and Danco Laboratories have expressed that mifepristone access should not be limited while the legal case is processed through the courts, stating chaos will occur for women seeking the drug and providers if limits take effect. One potential limit is a requirement for women to take higher doses of the drug than necessary according to the FDA.
Calls for the Supreme Court to have restrictions take effect immediately have been made by a group representing anti-abortion doctors and medical groups called Alliance Defending Freedom. Abortion opponents have been fighting against medication abortions, which make up over half of all US abortions, since the overturning of Roe v. Wade.
The suit against abortions was filed in Amarillo, Texas in November 2022. On April 7, 2023, a federal judge issues a ruling to revoke mifepristone’s FDA approval. The ruling was modified less than a week later to allow limited access during the case.
Restrictions include 3 in-person visits with a doctor to receive the drug, and approval only granted through 7 weeks of pregnancy despite the FDA approving it through 10 weeks of pregnancy. However, the FDA was ordered by a federal judge in Washington to preserve mifepristone under current rules in 17 Democratic-led states and the District of Columbia.
Reference
Supreme Court temporarily extends access to abortion pill. Yahoo news. April 19, 2023. Accessed April 19, 2023.https://www.yahoo.com/news/supreme-court-poised-rule-abortion-093654624.html
Recap on reproductive rights with David Hackney, MD, MS
December 20th 2022In this episode of Pap Talk, we spoke with David Hackney, MD, MS, maternal-fetal medicine physician at Case Western Reserve University and chair of ACOG's Ohio chapter for a full recap of where restrictions on reproductive rights have been and where they're going.
Listen
Adverse maternal outcomes after uterine conservation in placenta accreta spectrum
May 9th 2024A review of 5 studies reveals a significant 1 in 4 incidence of adverse maternal outcomes following uterine conservation in patients with placenta accreta spectrum, underlining the importance of expert multidisciplinary care.
Read More
In this episode of Pap Talk, Gloria Bachmann, MD, MSc, breaks down what it means to be a health care provider for incarcerated individuals, and explores the specific challenges women and their providers face during and after incarceration. Joined by sexual health expert Michael Krychman, MD, Bachmann also discusses trauma-informed care and how providers can get informed.
Listen
